BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1739 related articles for article (PubMed ID: 821605)

  • 1. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adrenals and estrogen in regression of mammary tumors during postpartum lactation in the rat.
    Aylsworth CF; Hodson CA; Berg G; Kledzik G; Meites J
    Cancer Res; 1979 Jul; 39(7 Pt 1):2436-9. PubMed ID: 445443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ; Kledzik GS; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term dysregulation of circadian and 17-beta estradiol-induced LH, prolactin and corticosterone secretion after dimethylbenz (a) anthracene administration in the Sprague-Dawley female rat.
    Yon de Jonage-Canonico MB; Lenoir V; Scholler R; Kerdelhué B
    Breast Cancer Res Treat; 2005 Jul; 92(1):47-50. PubMed ID: 15980990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism and production of precocious involution in the mammary glands of lactating rats.
    Varas SM; Muñoz EM; Hapon MB; Aguilera Merlo CI; Giménez MS; Jahn GA
    Reproduction; 2002 Nov; 124(5):691-702. PubMed ID: 12417008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM; Friesen HG
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estradiol and prolactin on galactosyltransferase and alpha-lactalbumin activities in rat mammary gland and mammary tumor.
    Ip C; Dao TL
    Cancer Res; 1978 Jul; 38(7):2077-83. PubMed ID: 418872
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.